Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 30 | 8 | 9 | 12 | 5 |
| Cost of Goods | N/A | 1 | 5 | 6 | 1 |
| Gross Profit | 30 | 7 | 4 | 6 | 4 |
| Operating Expenses | 992 | 1,790 | 1,559 | 1,603 | 2,057 |
| Operating Income | -962 | -1,782 | -1,550 | -1,591 | -2,052 |
| Interest Expense | 86 | 978 | 923 | 863 | 571 |
| Other Income | 2,706 | -1 | 37 | -164 | -84 |
| Pre-tax Income | 1,658 | -2,761 | -2,436 | -2,618 | -2,707 |
| Net Income Continuous | 1,658 | -2,761 | -2,436 | -2,618 | -2,707 |
| Minority Interests | N/A | -58 | -1 | N/A | -1 |
| Net Income | $1,658 | $-2,703 | $-2,435 | $-2,618 | $-2,706 |
| EPS Basic Total Ops | 0.77 | -2.66 | -2.11 | -2.46 | -2.46 |
| EPS Basic Continuous Ops | 0.77 | -2.55 | -2.26 | -2.43 | -2.51 |
| EPS Diluted Total Ops | 0.20 | -2.66 | -2.11 | -2.46 | -2.46 |
| EPS Diluted Continuous Ops | 0.19 | -2.55 | -2.26 | -2.43 | -2.51 |
| EBITDA(a) | $-949 | $-833 | $-651 | $-747 | $-1,475 |